Glucocorticoid-induced activation of caspase-8 protects the glucocorticoid-induced protein Gilz from proteasomal degradation and induces its binding to SUMO-1 in murine thymocytes

Cell Death and Differentiation

Volumn 18, Issue 1, 2011, Pages 183-190

  Delfino, D V ^a   Spinicelli, S ^a   Pozzesi, N ^a   Pierangeli, S ^a   Velardi, E ^a   Bruscoli, S ^a   Martelli, M P ^a   Pettirossi, V ^a   Falchi, L ^a   Kang, T B ^b   Riccardi, C ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

apoptosis; caspase 8; GC; Gilz; SUMO 1; thymocyte

Indexed keywords

CASPASE 8; DEXAMETHASONE; GLUCOCORTICOID INDUCED LEUCINE ZIPPER; LEUCINE ZIPPER PROTEIN; PROTEIN UBC9; SUMO 1 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ASSESSMENT; ENZYME ACTIVATION; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SUMOYLATION; THYMOCYTE;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES; BINDING SITES; CASPASE 8; CELLS, CULTURED; DEXAMETHASONE; GLUCOCORTICOIDS; MICE; MOLECULAR SEQUENCE DATA; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN BINDING; SUMO-1 PROTEIN; SUMOYLATION; THYROID GLAND; TRANSCRIPTION FACTORS; UBIQUITIN-CONJUGATING ENZYMES;

MURINAE;

EID: 78650169108     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2010.86     Document Type: Article

References (42)

1. Ashwell JD, Lu FWM, Vacchio MS. Glucocorticoids in T cell development and function. Annu Rev Immunol 2000; 18: 309-345.
2. King LB, Vacchio MS, Ashwell JD. To be or not to be: mutually antagonistic death signals regulate thymocyte apoptosis. Int Arch Allergy Immunol 1994; 105: 355-358.
3. Erlacher M, Knoflach M, Stec IE, Bock G, Wick G, Wiegers GJ. TCR signaling inhibits glucocorticoid-induced apoptosis in murine thymocytes depending on the stage of development. Eur J Immunol 2005; 35: 3287-3296.
4. Marchetti MC, Di Marco B, Cifone G, Migliorati G, Riccardi C. Dexamethasone-induced apoptosis of thymocytes: role of glucocorticoid receptor-associated Src kinase and caspase-8 activation. Blood 2003; 101: 585-593.
5. Cifone MG, Migliorati G, Parroni R, Marchetti C, Millimaggi D, Santoni A et al. Dexamethasone-induced thymocyte apoptosis: apoptotic signal involves the sequential activation of phosphoinositide-specific phospholipase C, acidic sphingomyelinase, and caspases. Blood 1999; 93: 2282-2296.
6. D'Adamio F, Zollo O, Moraca R, Ayroldi E, Bruscoli S, Bartoli A et al. A new dexamethasone-induced gene of the leucine zipper family protects T lymphocytes from TCR/CD3-activated cell death. Immunity 1997; 7: 803-812.
7. Cannarile L, Zollo O, D'Adamio F, Ayroldi E, Marchetti C, Tabilio A et al. Cloning, chromosomal assignment and tissue distribution of human GILZ, a glucocorticoid-induced gene. Cell Death Differ 2001; 8: 201-203.
8. Asselin-Labat ML, David M, Biola-Vidamment A, Lecoeuche D, Zennaro MC, Bertoglio J et al. GILZ, a new target for the transcription factor FoxO3, protects T lymphocytes from interleukin-2 withdrawal-induced apoptosis. Blood 2004; 104: 215-223.
9. Wang JC, Derynck NK, Nonaka DF, Khodabackhsh DB, Happ C, Yamamoto KR. Chromatin immunoprecipitation (ChIP) scanning identifies primary glucocorticoid receptor target genes. Proc Natl Acad Sci USA 2004; 101: 15603-15608.
10. Tynan SH, Lundeen SG, Allan GF. Celltype-specific bidirectional regulation of the glucocorticoid-induced leucine zipper (GILZ) gene by estrogen. J Steroid Biochem Mol Biol 2004; 91: 225-239.
11. Asselin-Labat ML, Biola-Vidamment A, Kerbrat S, Lombes M, Bertoglio J, Pallardy M. FoxO3 mediates antagonistic effects of glucocorticoids and interleukin-2 on glucocorticoid-induced leucine zipper expression. Mol Endocrinol 2005; 19: 1752-1764.
12. Chen W, Rgatsky I, Garabedan MJ. MED14 and MD1 dfferenall reglate target-specfic gene actvaton by the glcocorticod receptor. Mol Endocrnol 2006; 20: 560-572.
13. Van Der Laan S, Sarabdjitsingh RA, Van Batenburg MF, Lachize SB, Li H, Dijkmans TF et al. Chromatin immunoprecipitation scanning identifies glucocorticoid receptor binding regions in the proximal promoter of a ubiquitously expressed glucocorticoid target gene in brain. J Neurochem 2008; 106: 2515-2523.
14. Ayroldi E, Migliorati G, Bruscoli S, Marchetti C, Zollo O, Cannarile L et al. Modulation of T-cell activation by the glucocorticoid-induced leucine zipper factor via inhibition of nuclear factor-êB. Blood 2001; 98: 743-753.
15. Delfino DV, Agostini M, Spinicelli S, Vito P, Riccardi C. Decrease of Bcl-xL expression and augmentation of apoptosis in GILZ-overexpressing transgenic mice. Blood 2004; 104: 4134-4141.
16. Ayroldi E, Zollo O, Bastianelli A, Marchetti C, Agostini M, Di Virgilio R et al. GILZ mediates the antiproliferative activity of glucocorticoids by negative regulation of Ras signaling. J Clin Invest 2007; 117: 1605-1615.
17. Cannarile L, Fallarino F, Agostini M, Cuzzocrea S, Mazzon E, Vacca C et al. Increased Gilz expression in transgenic mice up-regulates Th-2 lymphokines. Blood 2006; 107: 1039-1047.
18. Cannarile L, Cuzzocrea S, Santucci L, Agostini M, Mazzon E, Esposito E et al. Glucocorticoid-induced leucine zipper is protective in Th1-mediated models of colitis. Gastroenterology 2009; 136: 530-541.
19. Cohen N, Mouly E, Hamdi H, Maillot M, Pallardy M, Godot V et al. GILZ expression in human dendritic cells redirects their maturation and prevents antigen-specific T lymphocyte response. Blood 2006; 107: 2037-2044.
20. Hamdi H, Godot V, Maillot MC, Prejean MV, Cohen N, Krzysiek R et al. Induction of antigen-specific regulatory T lymphocytes by human dendritic cells expressing the glucocorticoid-induced leucin zipper. Blood 2007; 110: 211-219.
21. +. J Am Soc Nephrol 2003; 14: 1107-1115.
22. Soundararajan R, Zhang TT, Wang J, Vandewalle A, Pearce D. A novel role for glucocorticoid-induced leucine zipper protein in epithelial sodium channel-mediated sodium transport. J Biol Chem 2005; 280: 39970-39981.
23. Ayroldi E, Riccardi C. Glucocorticoid-induced leucine zipper (GILZ): a new important mediator of glucocorticoid action. FASEB J 2009; 23: 3649-3658.
24. Delfino DV, Agostini M, Spinicelli S, Vacca C, Riccardi C. Inhibited cell death, NF-kB activity and increased IL-10 in TCR-triggered thymocytes of transgenic mice overexpressing the glucocorticoid-induced protein GILZ. Int Immunopharmacol 2006; 6: 1126-1134.
25. Hochstrasser M. Origin and function of ubiquitin-like proteins. Nature 2009; 458: 422-429.
26. Bergink S, Jentsch S. Principles of ubiquitin and SUMO modifications in DNA repair. Nature 2009; 458: 461-467.
27. Mabb AM, Miyamoto S. SUMO and NF-kappaB ties. Cell Mol Life Sci 2007; 64: 1979-1996.
28. Kang TB, Ben-Moshe T, Varfolomeef EE, Pewzner-Jung Y, Yogev N, Jurewicz A et al. Caspase-8 serves both apoptotic and nonapoptotic roles. J Immunol 2004; 173: 2976-2984.
29. Hennet T, Hagen FK, Tabak LA, Marth JD. T-cell-specific deletion of a polypeptide N-acetylgalactosaminyl-transferase gene by site-directed recombination. Proc Natl Acad Sci USA 1995; 92: 12070-12074.
30. Lawrence CP, Chow SC. FADD deficiency sensitises Jurkat T cells to TNF-α-dependent necrosis during activation-induced cell death. FEBS Lett 2005; 579: 6465-6472.
31. Herold MJ, McPherson KG, Reichardt HM. Glucocorticoids in T cell apoptosis and function. Cell Mol Life Sci 2006; 63: 60-72.
32. Reichardt HM, Kaestner KH, Tuckermann J, Kretz O, Wessely O, Bock R et al. DNA binding of the glucocorticoid receptor is not essential for survival. Cell 1998; 93: 531-541.
33. Tuckermann JP, Kleiman A, McPherson KG, Reichardt HM. Molecular mechanisms of glucocorticoids in the control of inflammation and lymphocyte apoptosis. Crit Rev Clin Lab Sci 2005; 42: 71-104.
34. Distelhorst CW. Recent insights into the mechanism of glucocorticoid-induced apoptosis. Cell Death Differ 2002; 9: 6-19.
35. Frankfurt O, Rosen ST. Mechanisms of glucocorticoid-induced apoptosis in hematologic malignancies: updates. Curr Opin Oncol 2004; 16: 553-563.
36. Salmena L, Lemmers B, Hakem A, Matysiak-Zablocki E, Murakami K, Au PY et al. Essential role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity. Genes Dev 2003; 17: 883-895.
37. Berger AB, Sexton KB, Bogyo M. Commonly used caspase inhibitors designed based on substrate specificity profiles lack selectivity. Cell Res 2006; 16: 961-963.
38. Zhu S, Sachdeva M, Wu F, Lu Z, Mo Y-Y. Ubc9 promotes breast cell invasion and metastasis in a sumoylation-independent manner. Oncogene 2009; 29: 1763-1772.
39. Sun X-M, Butterworth M, MacFarlane M, Dubiel W, Ciechanover A, Cohen GM. Caspase activation inhibits proteasome function during apoptosis. Mol Cell 2004; 14: 81-93.
40. Maelfait J, Beyaert R. Non-apoptotic functions of caspase-8. Biochem Pharmacol 2008; 76: 1365-1373.
41. Tang J, Kawadler H, Yang X. Lymphocyte life and death: the caspase-8 connection. Cancer Biol Ther 2005; 4: 700-702.
42. Su HC, Lenardo MJ. Genetic defects of apoptosis and primary immunodeficiency. Immunol Allergy Clin North Am 2008; 28: 329-351.